AFT Pharmaceuticals Limited (AFP) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aft Pharmaceuticals Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.119 Welcome, everybody, to AFT Pharmaceuticals' full year 2024 results briefing. 00:00:06.119 -- 00:00:11.946 Joining us today are Dr. Hartley Atkinson, Chief Executive Officer of AFT Pharmaceuticals, 00:00:11.946 -- 00:00:16.632 and Malcolm Tubby, Chief Financial Officer of AFT Pharmaceuticals. 00:00:16.632 -- 00:00:21.177 Before we begin, please note that any forward-looking statements mentioned on this call 00:00:21.177 -- 00:00:25.062 are based on management's current expectations and observations 00:00:25.062 -- 00:00:30.101 and are subject to risk and uncertainties that can cause actual results to differ from 00:00:30.101 -- 00:00:34.813 the forward-looking statement. AFD Pharmaceuticals does not undertake any obligation 00:00:34.813 -- 00:00:39.867 to update publicly any forward-looking statements to reflect the events or change circumstances 00:00:39.867 -- 00:00:43.757 after the call. With that, I will turn over the call to the speakers. 00:00:43.757 -- 00:00:47.001 Dr. Atkinson, please go ahead. 00:00:47.146 -- 00:00:50.290 Welcome, everyone. Thank you for joining us today. 00:00:50.290 -- 00:00:54.154 Just going to move through the investor presentation. 00:00:54.154 -- 00:00:56.357 This is for the last 00:00:56.357 -- 00:01:02.562 financial year, which is the period that goes to the 31st of March, 2024. 00:01:02.665 -- 00:01:07.050 And we've already essentially been through the disclaimer, 00:01:07.050 -- 00:01:10.274 so I'll take it that you've read that. Thank you. 00:01:10.274 -- 00:01:15.440 And then, as we've mentioned, presenting today is myself, Hartley Atkinson, 00:01:15.440 -- 00:01:19.291 and Malcolm Tubby our chief financial officer. 00:01:19.291 -- 00:01:24.757 And moving on to the summary page, as you can see, ...